Downloads
Abstract
Objective: To establish the proportion of cardiovascular diseases in COPD patients.
Object - Method: Cross-sectional descriptive study, sample n = 90 patients, convenient sampling. Study period from February 2017 to August 2017. The diagnosis of COPD was based on GOLD-2017 criteria. Heart failure and systemic hypertension were diagnosed on Framingham and JNC VII criteria. SPSS 20.0 was used for the analysis of data.
Results: The major cardiovascular diseases in COPD patients were cardiac arrhythmia (71.11%), systemic hypertension (66.67%), coronary artery disease (44.44%), degenerative valvular heart disease (46.67%), pulmonary hypertension (27.78%) and left heart failure (20.00%).
Conclusions: Cardiovascular diseases were very common in COPD patients. Of them, left heart failure is a challenge for the physician because the symptoms and signs of COPD and cardiovascular diseases are the same.
References
Đỗ Thị Tường Oanh (2000), “Khảo sát các yếu tố tiên lượng trong đợt cấp bệnh phổi tắc nghẽn mạn tính. Luận văn thạc sĩ y học. Đại học Y Dược Thành phố Hồ Chí Minh”.
Nguyễn Ngọc Phương Thư, Nguyễn Thanh Hiền, Dương Hiệp Hồ (2012), “Tỷ lệ các loại bệnh lý tim mạch ở bệnh nhân bệnh phổi tắc nghẽn mạn tính”. Tạp chí Y học thành phố Hồ Chí Minh, tr. 27 – 31.
Cao Thị Mỹ Thuý (2004), “Chẩn đoán, điều trị và theo dõi bệnh phổi tắc nghẽn mạn tính ngoại trú theo “Chiến lược toàn cầu đối với bệnh phổi tắc nghẽn mạn tính” – GOLD 2001”. Luận văn thạc sĩ y học.
American Thoracic Society (2016). Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease.
British Thoracic Society (2016), “Guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS”. Thorax, 52, pp. S1-28.
Falk JA., Kadiev S, Criner GJ., et al (2012), “Cardiac Disease in Chronic Obstructive Pulmonary Disease”. The American Thoracic Society, 5, pp.543-548.
Hanrahan JP, Grogan DR, Baumgartner RA et al (2010), “Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the effect of treatment with the inhaled long-acting beta2-agonists arformoterol and salmeterol”. Medicine(Baltimore), 87, pp. 319.
Mascarenhasa J, Azevedo A, Bettencourt P (2010), “Coexisting COPD and Heart Failure: Coexisting Chronic Obstructive Pulmonary Disease and Heart Failure: Epidemiology and the Interplay”. Curr Opin Pulm Med, 16, pp. 106-111.
NationalHeartLungandandBloodInstitute(NHLBI) and World Health Organization(WHO)(2016), “Global Initiative for Chronic Obstructive Lung Disease(GOLD)”. pp. 1-86.
Petty TL (2011), “Chronic Obstructive Pulmonary Disease (COPD). Best Practice of Medicine”.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2025 Journal of Clinical Medicine Hue Central Hospital